SCHEMBL407525

SCHEMBL407525

CCC(C)C(=O)NCCN(C)C

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
USP2 O75604 2/20 0.48
TSHR P16473 1/20 0.48
DNM1 Q05193 2/20 0.44
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 2/20 0.43
PKM P14618 1/20 0.43
GAA P10253 1/20 0.42
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA12 O43570 1/20 0.39
CA9 Q16790 1/20 0.39
ATM Q13315 1/20 0.38
PRSS1 P07477 1/20 0.37
TMPRSS15 P98073 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL407524 0.89 DNM1 (0.49) USP2TSHRDNM1ALDH1A1KDM4E
SCHEMBL13850713 0.83 USP2 (0.71) USP2TSHRDNM1ALDH1A1KDM4E
SCHEMBL14153993 0.83 TSHR (0.61) USP2TSHRALDH1A1GAACA1
SCHEMBL2876635 0.82 KDM4E (0.42) USP2TSHRDNM1ALDH1A1KDM4E
SCHEMBL12130522 0.82 ALDH1A1 (0.42) USP2TSHRALDH1A1KDM4EGAA
SCHEMBL17243836 0.81 USP2 (0.39) USP2TSHRDNM1ALDH1A1KDM4E
SCHEMBL2624391 0.81 ALDH1A1 (0.46) USP2TSHRDNM1ALDH1A1KDM4E
SCHEMBL19116010 0.81 ALDH1A1 (0.41) USP2TSHRDNM1ALDH1A1KDM4E
SCHEMBL13777003 0.79 TSHR (0.41) USP2TSHRALDH1A1KDM4EGAA
SCHEMBL30566038 0.79 MEN1 (0.53) USP2TSHRDNM1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230338415-A1 SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE GLYSCEND, INC. 2023-10-26 US disclosed
US-20230303514-A1 TLR7/8 ANTAGONISTS AND USES THEREOF MERCK PATENT GMBH (DE) 2023-09-28 US disclosed
US-20230288623-A1 OPTICAL FILM, OPTICAL LAMINATE, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2023-09-14 US disclosed
US-20230265346-A1 LIQUID CRYSTAL COMPOSITION, OPTICALLY ANISOTROPIC LAYER, LAMINATE, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2023-08-24 US disclosed
US-20230213823-A1 LIGHT ABSORPTION ANISOTROPIC FILM, LAMINATE, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2023-07-06 US disclosed
US-20230202146-A1 LAMINATE AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2023-06-29 US disclosed
US-20230159827-A1 LIQUID CRYSTAL COMPOSITION, FLUORINE-CONTAINING POLYMER, OPTICALLY ANISOTROPIC LAYER, LAMINATE, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2023-05-25 US disclosed
US-20170273893-A1 AGENT FOR TEMPORARY SHAPING OF KERATIN-CONTAINING FIBERS HAVING A MIXTURE OF CONDITIONING POLYMERS HENKEL AG & CO. KGAA (DE) 2017-09-28 US disclosed
US-20170179361-A1 THERMOELECTRIC CONVERSION ELEMENT, THERMOELECTRIC CONVERSION MODULE, METHOD FOR MANUFACTURING THERMOELECTRIC CONVERSION ELEMENT, AND METHOD FOR MANUFACTURING THERMOELECTRIC CONVERSION MODULE FUJIFILM CORPORATION (JP) 2017-06-22 US disclosed
EP-2490659-B1 COMPOSITION FOR THE TEMPORARY SHAPING OF KERATINIC FIBRES COMPRISING A NONIONIC PROPYLENEOXIDE-MODIFIED STARCH AND A CHITOSAN HENKEL AG & CO KGAA (DE) 2017-03-01 EP disclosed
US-20110045184-A1 AQUEOUS COLORANT DISPERSION AND METHOD FOR PRODUCING THE SAME, INK COMPOSITION, INK SET, IMAGE-FORMING METHOD, AND DISPERSANT FUJIFILM CORPORATION (JP) 2011-02-24 US disclosed
US-20100173224-A1 HYDROPHOBIC FLUORINATED POLYELECTROLYTE COMPLEX FILMS AND ASSOCIATED METHODS FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2010-07-08 US disclosed
US-7713629-B2 Hydrophobic fluorinated polyelectrolyte complex films and associated methods FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION (US) 2010-05-11 US disclosed
US-20090197791-A1 COPOLYMER CONTAINING ZWITTERIONIC UNITS AND OTHER UNITS, COMPOSITION COMPRISING THE COPOLYMER, AND USE RHODIA RECHERCHES ET TECHNOLOGIES (FR) 2009-08-06 US disclosed
US-20090197791-A1 COPOLYMER CONTAINING ZWITTERIONIC UNITS AND OTHER UNITS, COMPOSITION COMPRISING THE COPOLYMER, AND USE RHODIA RECHERCHES ET TECHNOLOGIES (FR) 2009-08-06 US disclosed
US-20080182936-A1 POLYMER FOR AN INK RECEIVING LAYER OF AN INKJET RECORDING ELEMENT HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2008-07-31 US disclosed
US-20070265174-A1 Hydrophobic Fluorinated Polyelectrolyte Complex Films And Associated Methods FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2007-11-15 US disclosed
US-7233378-B2 Anti-reflection film, method for producing the same, and image display device FUJIFILM CORPORATION (JP) 2007-06-19 US disclosed
US-7186786-B2 Chain transfer agents for RAFT polymerization in aqueous media UNIVERSITY OF SOUTHERN MISSISSIPPI (US) 2007-03-06 US disclosed
US-7179872-B2 Chain transfer agents for RAFT polymerization in aqueous media UNIVERSITY OF SOUTHERN MISSISSIPPI (US) 2007-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303514-A1 TLR7/8 ANTAGONISTS AND USES THEREOF TLR7, TLR8, TLR9 USP2 3215/4885TSHR 791/4885DNM1 1383/4885
US-20230338415-A1 SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE SLC10A2, PYGL, SLC10A1 USP2 3337/4885TSHR 1012/4885DNM1 3976/4885
US-20170273893-A1 AGENT FOR TEMPORARY SHAPING OF KERATIN-CONTAINING FIBERS HAVING A MIXTURE OF CONDITIONING POLYMERS KRT18, DSG1, CD69 USP2 1621/4885TSHR 3820/4885DNM1 4572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.